Gufic Biosciences Company Description
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally.
It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals.
The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.
In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products.
It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.
Country | India |
Founded | 1970 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,491 |
CEO | Pranav Choksi |
Contact Details
Address: S.M. House Mumbai, Maharashtra 400057 India | |
Phone | 91 22 6726 1000 |
Website | gufic.com |
Stock Details
Ticker Symbol | GUFICBIO |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE742B01025 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Pranav Jayesh Choksi | Chief Executive Officer and Whole Time Director |
Jayesh Pannalal Choksi | Chairman and MD |
Pankaj Jayakumar Gandhi | Whole-Time Director |
Devkinandan B. Roonghta | Chief Financial Officer |
Nagesh Yarrabathina | Chief Operating Officer |
Ami Naresh Shah | Company Secretary, Compliance Officer and Legal Manager |
Pinak Padhya | Associate Vice President - Sales and Marketing |
Sunil Desai | Head ? Human Resource Department |
Ashok Laxman Dev | President of Operation |
Shekhar Tarabir Aley | Senior Vice President - Critical Care SBUs, Nepal and Institution |